Cardiac Assist Devices Market - Size, Share and Forecast (2019-2026)

SKU: DMD379 | Last Updated On: 2019-08-13 | No. of Pages: 222 | Available Formats

( 29 Samples have been requested. )
In May 2019, Abiomed announced the commercial launch of the Impella CP with SmartAssist at the 2019 Society for Cardiovascular Angiography & Interventions (SCAI).

Cardiac Assist Devices Market Overview

Cardiac Assist Devices (CADs) are hemodynamic support devices that improve the pumping efficiency and maintain optimum blood flow throughout the body. They are used to treat end stage heart failure.

The global cardiac assist devices market size was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period (2019-2026).

 

Cardiac Assist Devices Market Dynamics

The cardiac assist devices market growth is driven by increasing prevalence of heart failures and number of patients with cardiovascular diseases (CVDs) which drives the demand for cardiac assist devices as they helps mechanically pump blood in patients with heart failures or weakened heart.

According to the National Health and Nutrition Examination Survey (NHANES) data (2016), an estimated 6.2 million American adults ≥20 years of age (2.2%) had heart failure between 2013 and 2016 compared with an estimated 5.7 million between 2009 and 2012. More than 5.7 million Americans suffer from heart failure, and there are approximately 915,000 new patients diagnosed with the disease annually. For patients with advanced heart failure stage, ventricular assist devices support the weakened heart by pumping blood through the body.

Increasing technological advancements in devices is also fuelling the growth of the cardiac assist devices globally. For instance, in June 2017, International Biophysics, a global medical device manufacturer, launched FloPump 32, the smallest centrifugal pumps in the world at 32ml prime, which is designed and intended to be used in conjunction with the Maquet® RotaFlow™ console. Also in August 2017, Abbott launched its Full MagLev™ HeartMate 3™ Left Ventricular Assist System (also known as an LVAD). The HeartMate 3 system provides a new option for physicians managing advanced heart failure patients in need of short-term hemodynamic support (bridge-to-transplant or bridge to myocardial recovery). Hence, the advancements in devices improve the quality of life for patients recovering from heart failures.

In addition, lack of heart donors, rising number of patients waiting for heart transplantation is driving the demand for alternative approaches such as ventricular assist devices (VADs). According to the organ donation data by the U.S. Department of Health & Human Services, approximately 115,000 people in the U.S. were on the waiting list for a lifesaving organ transplant by August 2017.

Rising government funding for product development along with ongoing research activities are also driving the growth of the cardiac assist devices market. For instance, in 2018, CorWave, a France based medical equipment company raised about USD 16.5 million to support CALYPSO Research and Development (R&D) program involved in the development of CorWave Neptune device, a new LVAD. Also, in 2016, Jarvik Heart received an approval for Investigational Device Exemption (IDE) clinical trial to test its miniature LVAD system in infants and children.

However, high cost of ventricular assist devices (VADs) for advanced heart failure coupled with expensive follow up care is restraining the growth of the cardiac assist devices market. On an average, the VADs costs around US$ 100,000 and the total procedure costs around US$ 700,000 over a six year period. The high cost of the device and procedures is too expensive for the low and middle income patient population, hence, declining the demand and growth of the market.

Cardiac Assist Devices Market Segment Analysis

By type, the global cardiac assist devices market is segmented into Ventricular Assist Device, Total Artificial Heart, Intra-Aortic Balloon Pump, and Others. Among these, the ventricular assist devices segment accounted for the largest market share of the cardiac assist devices in 2018, owing to the high adoption of the product among patients. Ventricular assist device (VAD) consists of an electric motor & a driveline which is implanted in the patient's chest. It helps in pumping the blood through the heart to the entire body and has the required force to distribute sufficient blood throughout the body.

The ventricular assist device is further classified into Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), and Bi-Ventricular Assist Device (BIVAD). Among these, left ventricular assist device held the largest market share of more than 70% in 2018, due to rising number of LVAD implantation. For instance, till May 2018, approximately, 26,600 heart failure patients were implanted with HEARTMATE II LVAD by Abbott. Also, increasing advancements in LVAD technologies is expected to further propel this demand. For instance, In October 2018, Abbott received US FDA approval for the HeartMate 3™ Left Ventricular Assist Device (LVAD) as a destination therapy for people living with advanced heart failure. Also, in 2016, ReliantHeart received CE mark, for aVAD-a left VAD. It includes features such as flow measurement and remote monitoring.

On the basis of application of cardiac assist devices, the market is segmented into bridge-to-transplant (BTT) therapy, destination therapy, and others (such as bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy). Among these, the destination therapy is estimated to grow at the highest CAGR during the forecast period (2019-2026), owing to high success rate, structural innovations, and higher quality of life with ventricular assist devices for destination therapy. For instance, from 2006 to 2007, more than 42% of VAD patients were listed for transplant and only 14.5% for destination therapy. The trend was reversed later, as from 2011 to 2013, there were more than 41% implanted devices were for destination therapy and only 21% for the transplant. In October 2019, Abbott received FDA approval for the HeartMate 3 left ventricular assist device (LVAD) as destination therapy for advanced heart failure patients ineligible for a transplant. The heart pump was approved as a bridge-to-transplant option in August 2017, but is now available for use as a destination therapy. It has been approved in Europe for both indications since October 2015. Hence, the increasing product approval by manufacturers is expected to increase the adoption of VAD for destination therapy.

Cardiac Assist Devices Market Geographical Analysis

North America is dominating the cardiac assist devices market in 2018 and estimated to hold largest market size over the forecast period (2019-2026), owing to the rising prevalence of heart failure cases. According to the American Heart Association, in 2017, approximately, 790,000 people in U.S. have heart attacks each year. In addition, rising number of people suffering from cardiovascular diseases and growing technological advancements are boosting the demand and adoption rate of cardiac assist devices in this region. In the United States, there are about 4,000 people on the heart transplant listed. Only about 2,000 hearts become available per year. The LVAD is used “bridge” these patients to transplant when waiting is no longer possible.

With increasing number of clinical trials, rising patient awareness about the variety of available products, the demand for cardiac assist devices is increasing in North America. There are various ventricular assist devices programs in various hospitals in this region, which leads to higher adoption rate among patients as these programs are aimed at creating awareness about ventricular assist device systems. For instance, Cleveland Clinic has one of the most experienced ventricular assist devices (VAD) programs in the United States. The Cleveland Clinic has access to FDA- approved ventricular assist devices, as well as new investigational devices. Other programs include Inova's Heart Failure Program, MedStar Advanced Heart Failure Program, and Michigan Medicine VAD Program.

Cardiac Assist Devices Market Competitive Landscape

The Cardiac Assist Devices market is dominated by few major players including Biophan Technologies, Berlin Heart GmbH, Calon Cardio-Technology Ltd., MAQUET GmbH & Co., Teleflex Incorporated, Heart Ware International, Abiomed Inc., Thoratec Corporation, SynCardia Systems, and Bioheart. The players are focusing on product approvals and developing innovative products to strengthen their product portfolio that intensifies the market competition. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the Cardiac Assist Devices market globally. For instance,

In May 2019, Abiomed launched commercially the Impella CP with SmartAssist at the 2019 Society for Cardiovascular Angiography & Interventions (SCAI).

In October 2018, Abbott received US FDA approval for the HeartMate 3™ Left Ventricular Assist Device (LVAD) as a destination therapy for people living with advanced heart failure.

In 2018, Calon Cardio-Technology has launched a clinical trial of the UK’s first artificial heart pump

Why Purchase the Report?

  • Visualize the composition of the cardiac assist devices in terms of types of cardiac assist devices highlighting the key commercial assets and players.
  • Identify commercial opportunities in cardiac assist devices market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of cardiac assist devices market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Cardiac Assist Devices Market

  1. Global Cardiac Assist Devices Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Cardiac Assist Devices Market – Market Definition and Overview

  3. Global Cardiac Assist Devices Market – Executive Summary

    1. Market Snippet by Type
    2. Market Snippet by Application
    3. Market Snippet by End-User
  4. Global Cardiac Assist Devices Market Dynamics

    1. Market Impacting Factors
    2. Drivers
      1. Rising Prevalence of Heart Failure
      2. Increasing Technological Advancement in Devices
    3. Restraints
      1. High Cost of Cardiac Assist Devices
    4. Opportunity
    5. Impact Analysis
  5. Global Cardiac Assist Devices Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Regulatory Analysis
    3. Supply Chain Analysis
    4. Pricing Analysis
  6. Global Cardiac Assist Devices Market – By Product

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
    3. Market Attractiveness Index, By Product Segment
      1. Ventricular Assist Device*
        1. Introduction
        2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
      2. Total Artificial Heart
      3. Intra-Aortic Balloon Pump
      4. Others
  7. Global Cardiac Assist Devices Market – By Application

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    3. Market Attractiveness Index, By Application Segment
      1. Bridge-to-transplant (BTT) therapy
        1. Introduction
        2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
      2. Destination therapy
      3. Others
  8. Global Cardiac Assist Devices Market – By End-User

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    3. Market Attractiveness Index, By End-User Segment
      1. Hospitals*
        1. Introduction
        2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
      2. Ambulatory Surgical Centres
      3. Others
  9. Global Cardiac Assist Devices Market – By Region

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  10. Global Cardiac Assist Devices Market – Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  11. Company Profiles

    1. Biophan Technologies, Inc.*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Berlin Heart GmbH
    3. Calon Cardio-Technology Ltd.
    4. MAQUET GmbH & Co.
    5. Teleflex Incorporated
    6. Heart Ware International
    7. Abiomed Inc.
    8. Thoratec Corporation
    9. SynCardia Systems
    10. Bioheart, Inc.
  12. Global Cardiac Assist Devices Market – Premium Insights

  13. Global Cardiac Assist Devices Market – DataM

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables

Table 1 Global Cardiac Assist Devices Market Value, By Product, 2018,2022 & 2026 ($ Million)

Table 2 Global Cardiac Assist Devices Market Value, By Application, 2018,2022 & 2026 ($ Million)

Table 3 Global Cardiac Assist Devices Market Value, By End-User, 2018,2022 & 2026 ($ Million)

Table 4 Global Cardiac Assist Devices Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 5 Global Cardiac Assist Devices Market Value, By Product, 2018,2022 & 2026 ($ Million)

Table 6 Global Cardiac Assist Devices Market Value, By Product, 2017-2026 ($ Million)

Table 7 Global Cardiac Assist Devices Market Value, By Application, 2018,2022 & 2026 ($ Million)

Table 8 Global Cardiac Assist Devices Market Value, By Application, 2017-2026 ($ Million)

Table 9 Global Cardiac Assist Devices Market Value, By End-User, 2018,2022 & 2026 ($ Million)

Table 10 Global Cardiac Assist Devices Market Value, By End-User, 2017-2026 ($ Million)

Table 11 Global Cardiac Assist Devices Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 12 Global Cardiac Assist Devices Market Value, By Region, 2017-2026 ($ Million)

Table 13 North America Cardiac Assist Devices Market Value, By Product, 2017-2026 ($ Million)

Table 14 North America Cardiac Assist Devices Market Value, By Application, 2017-2026 ($ Million)

Table 15 North America Cardiac Assist Devices Market Value, By End-User, 2017-2026 ($ Million)

Table 16 North America Cardiac Assist Devices Market Value, By Country, 2017-2026 ($ Million)

Table 17 South America Cardiac Assist Devices Market Value, By Product, 2017-2026 ($ Million)

Table 18 South America Cardiac Assist Devices Market Value, By Application, 2017-2026 ($ Million)

Table 19 South America Cardiac Assist Devices Market Value, By End-User, 2017-2026 ($ Million)

Table 20 South America Cardiac Assist Devices Market Value, By Country, 2017-2026 ($ Million)

Table 21 Europe Cardiac Assist Devices Market Value, By Product, 2017-2026 ($ Million)

Table 22 Europe Cardiac Assist Devices Market Value, By Application, 2017-2026 ($ Million)

Table 23 Europe Cardiac Assist Devices Market Value, By End-User, 2017-2026 ($ Million)

Table 24 Europe Cardiac Assist Devices Market Value, By Country, 2017-2026 ($ Million)

Table 25 Asia-Pacific Cardiac Assist Devices Market Value, By Product, 2017-2026 ($ Million)

Table 26 Asia-Pacific Cardiac Assist Devices Market Value, By Application, 2017-2026 ($ Million)

Table 27 Asia-Pacific Cardiac Assist Devices Market Value, By End-User, 2017-2026 ($ Million)

Table 28 Asia-Pacific Cardiac Assist Devices Market Value, By Country, 2017-2026 ($ Million)

Table 29 Middle East & Africa Cardiac Assist Devices Market Value, By Product, 2017-2026 ($ Million)

Table 30 Middle East & Africa Cardiac Assist Devices Market Value, By Application, 2017-2026 ($ Million)

Table 31 Middle East & Africa Cardiac Assist Devices Market Value, By End-User, 2017-2026 ($ Million)

Table 32 Biophan Technologies, Inc.: Overview

Table 33 Biophan Technologies, Inc.: Product Portfolio

Table 34 Biophan Technologies, Inc.: Key Developments

Table 35 Berlin Heart GmbH: Overview

Table 36 Berlin Heart GmbH: Product Portfolio

Table 37 Berlin Heart GmbH: Key Developments

Table 38 Calon Cardio-Technology Ltd.: Overview

Table 39 Calon Cardio-Technology Ltd.: Product Portfolio

Table 40 Calon Cardio-Technology Ltd.: Key Developments

Table 41 MAQUET GmbH & Co.: Overview

Table 42 MAQUET GmbH & Co.: Product Portfolio

Table 43 MAQUET GmbH & Co.: Key Developments

Table 44 Teleflex Incorporated: Overview

Table 45 Teleflex Incorporated: Product Portfolio

Table 46 Teleflex Incorporated: Key Developments

Table 47 Heart Ware International: Overview

Table 48 Heart Ware International: Product Portfolio

Table 49 Heart Ware International: Key Developments

Table 50 Abiomed Inc.: Overview

Table 51 Abiomed Inc.: Product Portfolio

Table 52 Abiomed Inc.: Key Developments

Table 53 Thoratec Corporation: Overview

Table 54 Thoratec Corporation: Product Portfolio

Table 55 Thoratec Corporation: Key Developments

Table 56 SynCardia Systems: Overview

Table 57 SynCardia Systems: Product Portfolio

Table 58 SynCardia Systems: Key Developments

Table 59 Bioheart, Inc.: Overview

Table 60 Bioheart, Inc.: Product Portfolio

Table 61 Bioheart, Inc.: Key Developments

 List of Figures

Figure 1 Global Cardiac Assist Devices Market Share, By Product, 2018 & 2026 (%)

Figure 2 Global Cardiac Assist Devices Market Share, By Application, 2018 & 2026 (%)

Figure 3 Global Cardiac Assist Devices Market Share, By End-User, 2018 & 2026 (%)

Figure 4 Global Cardiac Assist Devices Market Share, By Region, 2018 & 2026 (%)

Figure 5 Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 6 Global Cardiac Assist Devices Market Y-o-Y Growth, By Product, 2018-2026 (%)

Figure 7 Ventricular Assist Device: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 8 Total Artificial Heart: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 9 Intra-Aortic Balloon Pump: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 10 Others: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 11 Global Cardiac Assist Devices Market Y-o-Y Growth, By Application, 2018-2026 (%)

Figure 12 Bridge-to-transplant (BTT) therapy: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 13 Destination therapy: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 14 Others: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 15 Global Cardiac Assist Devices Market Y-o-Y Growth, By End-User, 2018-2026 (%)

Figure 16 Hospitals & Clinics: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 17 Ambulatory Surgical Centres: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 18 Others: Global Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 19 Global Cardiac Assist Devices Market Y-o-Y Growth, By Region, 2018-2026 (%)

Figure 20 North America Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 21 North America Cardiac Assist Devices Market Share, By Product, 2018 & 2026 (%)

Figure 22 North America Cardiac Assist Devices Market Share, By Application, 2018 & 2026 (%)

Figure 23 North America Cardiac Assist Devices Market Share, By End-User, 2018 & 2026 (%)

Figure 24 North America Cardiac Assist Devices Market Share, By Country, 2018 & 2026 (%)

Figure 25 South America Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 26 South America Cardiac Assist Devices Market Share, By Product, 2018 & 2026 (%)

Figure 27 South America Cardiac Assist Devices Market Share, By Application, 2018 & 2026 (%)

Figure 28 South America Cardiac Assist Devices Market Share, By End-User, 2018 & 2026 (%)

Figure 29 South America Cardiac Assist Devices Market Share, By Country, 2018 & 2026 (%)

Figure 30 Europe Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 31 Europe Cardiac Assist Devices Market Share, By Product, 2018 & 2026 (%)

Figure 32 Europe Cardiac Assist Devices Market Share, By Application, 2018 & 2026 (%)

Figure 33 Europe Cardiac Assist Devices Market Share, By End-User, 2018 & 2026 (%)

Figure 34 Europe Cardiac Assist Devices Market Share, By Country, 2018 & 2026 (%)

Figure 35 Asia-Pacific Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 36 Asia-Pacific Cardiac Assist Devices Market Share, By Product, 2018 & 2026 (%)

Figure 37 Asia-Pacific Cardiac Assist Devices Market Share, By Application, 2018 & 2026 (%)

Figure 38 Asia-Pacific Cardiac Assist Devices Market Share, By End-User, 2018 & 2026 (%)

Figure 39 Asia-Pacific Cardiac Assist Devices Market Share, By Country, 2018 & 2026 (%)

Figure 40 Middle East & Africa Cardiac Assist Devices Market Value, 2017-2026 ($ Million)

Figure 41 Middle East & Africa Cardiac Assist Devices Market Share, By Product, 2018 & 2026 (%)

Figure 42 Middle East & Africa Cardiac Assist Devices Market Share, By Application, 2018 & 2026 (%)

Figure 43 Middle East & Africa Cardiac Assist Devices Market Share, By End-User, 2018 & 2026 (%)

Figure 44 Biophan Technologies, Inc.: Financials

Figure 45 Berlin Heart GmbH: Financials

Figure 46 Calon Cardio-Technology Ltd.: Financials

Figure 47 MAQUET GmbH & Co.: Financials

Figure 48 Teleflex Incorporated: Financials

Figure 49 Heart Ware International: Financials

Figure 50 Abiomed Inc.: Financials

Figure 51 Thoratec Corporation: Financials

Figure 52 SynCardia Systems: Financials

Figure 53 Bioheart, Inc.: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report